Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong
· Delayed Price · Currency is HKD
55.45
+1.30 (2.40%)
Mar 10, 2026, 11:49 AM HKT
Xuanzhu Biopharmaceutical Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.02 | 0.02 | 0 | 0.02 |
| Net Debt / Equity Ratio | -0.13 | -0.26 | -0.39 | -0.68 | -0.71 | -0.20 |
| Net Debt / EBITDA Ratio | 0.20 | 0.46 | 1.37 | 3.02 | 4.29 | 0.33 |
| Net Debt / FCF Ratio | 0.55 | 1.92 | 3.68 | 2.47 | 3.62 | 0.23 |
| Asset Turnover | - | 0.02 | - | - | - | - |
| Inventory Turnover | - | 0.25 | - | - | - | - |
| Quick Ratio | 0.78 | 1.45 | 3.24 | 19.95 | 14.26 | 2.45 |
| Current Ratio | 1.43 | 2.06 | 3.79 | 21.28 | 14.95 | 3.13 |
| Return on Equity (ROE) | - | -53.84% | - | -29.47% | -16.87% | - |
| Return on Assets (ROA) | - | -27.97% | - | -15.83% | -14.54% | - |
| Return on Capital Employed (ROCE) | -63.00% | -55.40% | -28.80% | -23.00% | -17.70% | -60.20% |
| Buyback Yield / Dilution | -14.22% | - | -14.22% | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.